HHLA2 Antikörper (AA 172-258) (FITC)
-
- Target Alle HHLA2 Antikörper anzeigen
- HHLA2 (HERV-H LTR-Associating 2 (HHLA2))
-
Bindungsspezifität
- AA 172-258
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HHLA2 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human HERV-H LTR-associating protein 2 protein (172-258AA)
- Isotyp
- IgG
- Top Product
- Discover our top product HHLA2 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- HHLA2 (HERV-H LTR-Associating 2 (HHLA2))
- Andere Bezeichnung
- HHLA2 (HHLA2 Produkte)
- Synonyme
- B7H7 antikoerper, HERV-H LTR-associating 2 antikoerper, HHLA2 antikoerper, hhla2 antikoerper
- Hintergrund
-
Background: Through interaction with TMIGD2, costimulates T-cells in the context of TCR-mediated activation. Enhances T-cell proliferation and cytokine production via an AKT-dependent signaling cascade.
Aliases: B7H7 antibody, HERV H LTR associating 2 antibody, HERV-H LTR-associating protein 2 antibody, HHLA 2 antibody, HHLA2 antibody, HHLA2_HUMAN antibody, Human endogenous retrovirus H long terminal repeat associating protein 2 antibody, Human endogenous retrovirus-H long terminal repeat-associating protein 2 antibody
- UniProt
- Q9UM44
-